{
  "paper_metadata": {
    "pmid": "38911588",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the p.Ile88Leu variant in the TTR gene, focusing on its clinical significance, patient demographics, and treatment outcomes."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Ile88Leu",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 22,
        "demographics": "Median age 73 years (IQR: 9), age at diagnosis 72 years (IQR: 10)",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 22,
        "affected_count": 22,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 73,
          "age_at_onset": null,
          "age_at_diagnosis": 72,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Polyneuropathy FAP stage 1 or 2",
          "evidence_sentence": "A total of 22 patients were included in the study; the median age was 73 years (IQR: 9), the age at diagnosis was 72 years (IQR: 10), and the disease duration was 1.6 years (IQR: 2.3)."
        }
      ],
      "functional_data": {
        "summary": "The p.Ile88Leu variant is associated with a high mortality rate and significant neurological symptoms.",
        "assays": []
      },
      "segregation_data": "The variant is associated with hereditary transthyretin amyloidosis.",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 1",
      "additional_notes": "The study provides real-world evidence on the effectiveness of patisiran in patients with this variant.",
      "key_quotes": [
        "The most common variant in patients and asymptomatic carriers is p.Ile88Leu.",
        "We observed stability of all considered neurological and cardiological parameters at 9\u201312 months after the beginning of patisiran treatment."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper focused on a specific variant in the TTR gene."
  }
}